Upadacitinib for moderate to severe atopic dermatitis.
Navarro-Triviño F, Alcantara-Luna S, Domínguez-Cruz J, Galán-Gutiérrez M, Ruiz-Villaverde R, Pereyra-Rodriguez JJ, Armario-Hita JC.
Immunotherapy. 2023 Aug;15(11):799-808. doi: 10.2217/imt-2023-0037. Epub 2023 May 17.
Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
Johnston L, Poelman S, Metelitsa A.
Skin Therapy Lett. 2025 Jul;30(4):1-7.
Comparative efficacy and safety of abrocitinib, baricitinib, and upadacitinib for moderate-to-severe atopic dermatitis: A network meta-analysis.
Wan H, Jia H, Xia T, Zhang D.
Dermatol Ther. 2022 Sep;35(9):e15636. doi: 10.1111/dth.15636. Epub 2022 Jul 27.
Tralokinumab for Moderate-to-Severe Atopic Dermatitis in Adults.
Abduelmula A, Rankin BD, Mufti A, Yeung J, Prajapati VH.
Skin Therapy Lett. 2023 Jan;28(1):1-6.
Dupilumab for Moderate-to-Severe Atopic Dermatitis.
Vangipuram R, Tyring SK.
Skin Therapy Lett. 2017 Nov;22(6):1-4.
An evaluation of abrocitinib for moderate-to-severe atopic dermatitis.
Labib A, Yosipovitch G.
Expert Rev Clin Immunol. 2022 Nov;18(11):1107-1118. doi: 10.1080/1744666X.2022.2126353. Epub 2022 Sep 29.
Fecal microbiota transplantation against moderate-to-severe atopic dermatitis: A randomized, double-blind controlled explorer trial.
Liu X, Luo Y, Chen X, Wu M, Xu X, Tian J, Gao Y, Zhu J, Wang Z, Zhou Y, Zhang Y, Wang X, Li W, Lu Q, Yao X.
Allergy. 2025 May;80(5):1377-1388. doi: 10.1111/all.16372. Epub 2024 Oct 29.
Baricitinib: A Review in Moderate to Severe Atopic Dermatitis.
Hoy SM.
Am J Clin Dermatol. 2022 May;23(3):409-420. doi: 10.1007/s40257-022-00684-1. Epub 2022 May 3.
Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND).
Shi VY, Bhutani T, Fonacier L, Deleuran M, Shumack S, Valdez H, Zhang F, Chan GL, Cameron MC, Yin NC.
J Am Acad Dermatol. 2022 Aug;87(2):351-358. doi: 10.1016/j.jaad.2022.04.009. Epub 2022 Apr 16.
Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis.
Yosipovitch G, Reaney M, Mastey V, Eckert L, Abbé A, Nelson L, Clark M, Williams N, Chen Z, Ardeleanu M, Akinlade B, Graham NMH, Pirozzi G, Staudinger H, Plaum S, Radin A, Gadkari A.
Br J Dermatol. 2019 Oct;181(4):761-769. doi: 10.1111/bjd.17744. Epub 2019 May 1.
